653
edits
Difference between revisions of "Extramammary Paget disease"
Jump to navigation
Jump to search
→IHC
(→DDx) |
(→IHC) |
||
| Line 112: | Line 112: | ||
*Differentiation markers GATA - apocrine and urothelial; p63 - squamous, CDX2 - colorectal | *Differentiation markers GATA - apocrine and urothelial; p63 - squamous, CDX2 - colorectal | ||
*Notice urothelial origin Paget can show immunos patterns "transitional" between glandular and squamous epithelium | |||
**A CK20 negative urothelial origin EMPD could show a similar immunoprofile as a primary cutaneous EMPD. | |||
*Notice that you do not need to include markers for mammary Paget disease or Toker cells. | |||
*Do not rely on CK7 alone as CK7 may be positive in pagetoid squamous cell carcinoma in situ or extramammary Paget disease <ref>{{Cite journal | last1 = Raju | first1 = RR. | last2 = Goldblum | first2 = JR. | last3 = Hart | first3 = WR. | title = Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia. | journal = Int J Gynecol Pathol | volume = 22 | issue = 2 | pages = 127-35 | month = Apr | year = 2003 | doi = | PMID = 12649666 }}</ref> | |||
*p16 is not helpful in this DDX as VIN, EMPD and urothelial carcioma can be positive for this marker <ref>{{Cite journal | last1 = Sah | first1 = SP. | last2 = McCluggage | first2 = WG. | title = Florid vulval Paget disease exhibiting p16 immunoreactivity and mimicking classic VIN. | journal = Int J Gynecol Pathol | volume = 32 | issue = 2 | pages = 221-7 | month = Mar | year = 2013 | doi = 10.1097/PGP.0b013e31825909f6 | PMID = 23370646 }}</ref> | |||
Roughly and with caveats........ | Roughly and with caveats........ | ||